DIAアカウントをお持ちの場合、サインインしてください。

サインイン

ユーザーIDをお忘れですか? or パスワードをお忘れですか?

Virtual Event

2021年3月15日 (月) 午前 9:00 - 2021年3月19日 (金) 午後 4:30

(Central Europe Standard Time)

4051 Basel, Switzerland

DIA EUROPE 2021

Advancing Nanomedicines Into the Clinics by Applying a Multidisciplinary Approach

Session Chair(s)

Mark   van Eldijk

Mark van Eldijk

Group leader

Ardena, Belgium

Nanomedines are used in a variety of ways, both for drug delivery purposes and as tools for medical applications such as imaging and tissue engineering. Especially the benefit of nanomedicines in drug delivery has been proven as they confer unique pharmacokinetic and therapeutic effects such as improved dissolution rate and oral bioavailability, targeted delivery, improved efficacy, and decreased toxicity. As the control of materials in the nanometer size range requires scientifically demanding chemistry, analysis and manufacturing techniques special capacities are required to enable the clinical development of nanomedicines as versatile units. Since clinical development requires different capacities, it is extremely important to have access to a linked, multidisciplinary technology portfolio. In this session we would like to share experiences about which competencies are required and how capacities can be optimally used to allow nanomedicines to advance in clinical development.

Speaker(s)

Mark   van Eldijk

Technology Deep Dive

Mark van Eldijk

Ardena, Belgium

Group leader

最新情報や機会を逃さないで

DIAのメールを購読すれば、常に最新の業界情報やイベント情報を得ることができます。